ESC Premium Access

Can we teach heart failure drugs new tricks?

Event: ESC CONGRESS 2017
Topic: Pharmacologic therapy
Session type: Rapid Fire Abstracts
Date: 26 August 2017
Time: 13:30 - 15:00

Congress Session

10 presentations in this session

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Speaker: Doctor Y. Mareev (Moscow, RU)
Thumbnail

Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT.

Speaker: Professor J. Cleland (Glasgow, GB)
Thumbnail

The glucagon-like peptide 1 agonist liraglutide increases heart rate in heart failure patients

Speaker: Doctor R. Tougaard (Horsens, DK)
Thumbnail

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Speaker: Doctor M. Zile (Charleston, S C, US)
Thumbnail

Long-term outcome in myocardial infarction patients with heart failure treated with aldosterone receptor antagonist in relation to ejection fraction and kidney function

Speaker: Doctor I. Lofman (Stockholm, SE)
Thumbnail

Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials

Speaker: Doctor I. Pina (Philadelphia, US)
Thumbnail

Cardiovascular hospitalisation and death by subgroup in iron-deficient patients with heart failure treated with intravenous ferric carboxymaltose: an individual patient meta-analysis.

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

Cardiovascular and renal outcomes in iron-deficient patients with HFrEF and renal dysfunction treated with i.v. ferric carboxymaltose: An individual patient data meta-analysis

Speaker: Professor P. Ponikowski (Wroclaw, PL)
Thumbnail

Effect of i.v. ferric carboxymaltose iron therapy on symptoms and functional status in iron-deficient patients with HFrEF and renal dysfunction: An individual patient data meta-analysis

Speaker: Professor P. Ponikowski (Wroclaw, PL)
Thumbnail

Oral iron administration in chronic heart failure patients with iron deficiency: a randomized, placebo-control and double-blind pilot study.

Speaker: Professor M. Simoes (Ribeirao Preto, BR)
Thumbnail

10 speakers from this session

Doctor Yury Mareev

National Research Center for Preventive Medicine, Moscow (Russian Federation)
0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
3 followers

Doctor Rasmus Stilling Tougaard

Horsens Hospital, Horsens (Denmark)
0 follower

Doctor Michael Zile

Medical University of South Carolina & VA Med Ctr, Charleston, S C (United States of America)
3 presentations
0 follower

Doctor Ida Lofman

Karolinska University Hospital, Stockholm (Sweden)
2 presentations
0 follower

Doctor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
22 presentations
0 follower

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
116 presentations
3 followers

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
68 presentations
8 followers

Professor Piotr Ponikowski

Wroclaw Medical University, Wroclaw (Poland)
68 presentations
8 followers

Professor Marcus Vinicius Simoes

Medical School of Ribeirao Preto, Ribeirao Preto (Brazil)
1 follower

This platform is supported by

logo Novo Nordisk